We are live on
!
Find out more
FFM
Fisher Funds Management Portfolio holdings
AUM
$3.52B
1-Year Est. Return
17.59%
This Fund
S&P 500
This Quarter
Est. Return
-2.66%
1 Year Est. Return
+17.59%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.12B
AUM Growth
-$21.9M
(-0.53%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
3.79%
Top 10 Holdings %
Top 10 Hldgs %
35.63%
Holding
164
New
–
Increased
22
Reduced
12
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$33.1M |
| 2 |
Microsoft
MSFT
|
+$30.3M |
| 3 |
Floor & Decor
FND
|
+$26.4M |
| 4 |
Amazon
AMZN
|
+$24.9M |
| 5 |
Intuitive Surgical
ISRG
|
+$20.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$18M |
| 2 |
Mastercard
MA
|
+$17.5M |
| 3 |
Icon
ICLR
|
+$10.3M |
| 4 |
Edwards Lifesciences
EW
|
+$8.78M |
| 5 |
Kinder Morgan
KMI
|
+$7.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.85% |
| 2 | Technology | 22.78% |
| 3 | Financials | 11.54% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Communication Services | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Exelon
EXC
$47.2B
| $11.1M | 0.27% |
240,789
| – | – |
|
77
Aflac
AFL
$64.9B
| $11.1M | 0.27% |
99,516
| – | – |
|
78
Everest Group
EG
$14.5B
| $10.5M | 0.25% |
28,822
| – | – |
|
79
Elevance Health
ELV
$81.5B
| $10.4M | 0.25% |
23,879
| – | – |
|
80
Nucor
NUE
$58.6B
| $10.4M | 0.25% |
86,252
| – | – |
|
81
Amgen
AMGN
$208B
| $10.3M | 0.25% |
33,156
| – | – |
|
82
Abbott
ABT
$183B
| $10.3M | 0.25% |
77,816
| – | – |
|
83
Visa
V
$684B
| $10M | 0.24% |
28,662
| – | – |
|
84
McKesson
MCK
$100B
| $9.81M | 0.24% |
14,575
| – | – |
|
85
Eli Lilly
LLY
$1.02T
| $9.59M | 0.23% |
11,612
| – | – |
|
86
Fidelity National Financial
FNF
$13.9B
| $9.51M | 0.23% |
146,196
| – | – |
|
87
NiSource
NI
$21.3B
| $9.29M | 0.23% |
231,813
| – | – |
|
88
Ford
F
$58.5B
| $9.1M | 0.22% |
906,980
| – | – |
|
89
Atmos Energy
ATO
$28.8B
| $8.5M | 0.21% |
54,999
| – | – |
|
90
Warner Bros
WBD
$65.9B
| $8.29M | 0.2% |
772,146
| – | – |
|
91
CF Industries
CF
$19.2B
| $8.2M | 0.2% |
104,889
| – | – |
|
92
CVS Health
CVS
$133B
| $7.76M | 0.19% |
114,549
| – | – |
|
93
Intel
INTC
$455B
| $7.69M | 0.19% |
338,569
| – | – |
|
94
Bank of America
BAC
$435B
| $7.55M | 0.18% |
180,815
| – | – |
|
95
Gilead Sciences
GILD
$162B
| $7.41M | 0.18% |
66,190
| – | – |
|
96
CBRE Group
CBRE
$42.5B
| $7.4M | 0.18% |
56,569
| – | – |
|
97
Analog Devices
ADI
$179B
| $7.39M | 0.18% |
36,630
| – | – |
|
98
Travelers Companies
TRV
$78.1B
| $7.38M | 0.18% |
27,911
| – | – |
|
99
CRH
CRH
$63.2B
| $7.33M | 0.18% |
83,296
| – | – |
|
100
LyondellBasell Industries
LYB
$20B
| $7.22M | 0.18% |
102,625
| – | – |
|
Similar funds
TH
ACA
BCP
TYCC
TCM
AAP
DILIC
KCM
Fisher Funds Management's Q1 2025 Portfolio in Review
As of Q1 2025, Fisher Funds Management held 164 positions worth $4.12B, down 0.53% from $4.15B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Fisher Funds Management deployed $156M of net new capital in Q1 2025, adding to 22 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was UnitedHealth, an estimated $18M trimmed.
- Fisher Funds Management added most to DexCom in Q1 2025, an estimated $33.1M increase.
- Fisher Funds Management's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $18M.
- Fisher Funds Management's ten largest holdings make up 36% of its $4.12B portfolio in Q1 2025.
- Fisher Funds Management opened 0 new positions and closed 0 in Q1 2025.
- Fisher Funds Management's portfolio value fell 0.53% quarter-over-quarter to $4.12B.
Based on Fisher Funds Management's 13F filing for Q1 2025, filed 29 Apr 2025.